Navigation Links
New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
Date:1/17/2008

BOSTON, Jan. 17 /PRNewswire-USNewswire/ -- Cataract surgery involves removing a clouded natural lens from inside the eye and replacing it with a plastic one. While the operation itself hasn't changed much over recent years, the plastic lenses have. The biggest advantage of the newer lenses is their ability to reduce the need for glasses after surgery, says a newly updated report from Harvard Medical School.

The Aging Eye: Preventing and Treating Eye Disease explains that the older types of plastic lenses help people see well at one distance -- be it close up, far away, or at a medium distance. Two newer types of lenses, accommodating and multifocal, let the eye focus at varying distances, so fewer patients need glasses for reading or distance vision.

The accommodating intraocular lens has hinges on its sides that permit it to move as the eye's ciliary muscle contracts or relaxes. This improves the ability to change focus from near to far. The multifocal intraocular lens uses a new type of refractive technology to provide focus for multiple distances. This type has either small, concentric circular ridges that permit the eye to change its range of focus or broad zones to provide near, intermediate, and distance vision.

Insurers may not cover these newer lenses, and some people cannot receive them because of other medical issues. The most common problems with the newer lenses are glare, halos, and the continued need for eyeglasses.

The Aging Eye, a 48-page Special Health Report edited by Laura Fine, M.D., and Jeffrey Heier, M.D., both instructors of ophthalmology at Harvard Medical School, also covers

-- glaucoma, cataract, diabetic retinopathy, and other common eye problems

-- how diet affects eye health

-- symptoms that should send you to the ophthalmologist

-- tips for safeguarding your sight.

The Aging Eye: Preventing and Treating Eye Disease is available for $16 from Harvard Health Pu
'/>"/>

SOURCE Harvard Health Publications
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
2. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
3. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
4. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
5. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
6. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
9. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
10. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
11. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Rose, baseball,s all-time hits leader, is the new spokesperson for ... Pharma has announced. "Pete,s a Hall of Famer ... on board with Myoflex," said Ducere Pharma Chief Executive Officer ... is known across all generations. The passion and intensity that ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)...  Mallinckrodt plc (NYSE: MNK ) announced today ... repurchase program. The open-ended authorization permits the company to ... shares. "Funding additional initiatives and seeking ... continue to pursue a range of focused growth strategies," ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 2, 2011 Reportlinker.com announces ... report is available in its ... Cardiology Devices: World Market Prospects ... http://www.reportlinker.com/p0663863/Interventional-Cardiology-Devices-World-Market-Prospects-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine Our ...
... 2, 2011 Syndax Pharmaceuticals, Inc ., a ... in a subset of patients from ENCORE 301, a ... entinostat in advanced breast cancer patients, will be presented ... for Cancer Research (AACR) Molecular Targets and Cancer Therapeutics ...
Cached Medicine Technology:Interventional Cardiology Devices: World Market Prospects 2011-2021 2Interventional Cardiology Devices: World Market Prospects 2011-2021 3Interventional Cardiology Devices: World Market Prospects 2011-2021 4Interventional Cardiology Devices: World Market Prospects 2011-2021 5Interventional Cardiology Devices: World Market Prospects 2011-2021 6Interventional Cardiology Devices: World Market Prospects 2011-2021 7Interventional Cardiology Devices: World Market Prospects 2011-2021 8Interventional Cardiology Devices: World Market Prospects 2011-2021 9Interventional Cardiology Devices: World Market Prospects 2011-2021 10Interventional Cardiology Devices: World Market Prospects 2011-2021 11Interventional Cardiology Devices: World Market Prospects 2011-2021 12Interventional Cardiology Devices: World Market Prospects 2011-2021 13Interventional Cardiology Devices: World Market Prospects 2011-2021 14Pharmacodynamic Data from Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the AACR Molecular Targets and Cancer Therapeutics Conference 2011 2Pharmacodynamic Data from Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the AACR Molecular Targets and Cancer Therapeutics Conference 2011 3
(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... - Adjusted Diluted EPS (1) was $0.42 -- Annual Guidance Narrowed to $2.05 to $2.18 Adjusted Diluted ... West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its results for the first quarter ... Three Months Ended, ... ...
... April 30 Quigley Pharma Inc., www.quigleyco.com ... Corporation (Nasdaq: QGLY ) announced today that ... of diabetic peripheral neuropathy, demonstrated a significant improvement in ... the group treated with QR333. The compound was ...
... PARK CITY, Utah, April 30 Nutraceutical International Corporation (Nasdaq: ... 2009 second quarter ended March 31, 2009. Net sales ... to $44.4 million for the same quarter of fiscal 2008.Primarily ... recession and the related turmoil in the equity markets, there ...
... Gentiva Health Services, Inc. (Nasdaq: GTIV ), ... the following 2009 first quarter results: , ... revenues of $288.9 million for the quarter ended March 29, ... $77.8 million from its CareCentrix business unit, for the quarter ...
... April 3 In conjunction with its first quarter 2009 earnings ... 2009), Covance Inc. (NYSE: CVD ) is pleased to ... will be broadcast live over the Internet on Thursday, April 30, ... First Quarter 2009 Earnings Webcast and Slide Presentation, ...
... increases 9 percent to $24.9 billion- GAAP earnings from ... decrease 10 percent to $350 million on a non-GAAP ... decline 15 percent to $0.87 and decrease 10 percent ... Cardinal Health, a global provider of products and ...
Cached Medicine News:Health News:West Announces First Quarter 2009 Results 2Health News:West Announces First Quarter 2009 Results 3Health News:West Announces First Quarter 2009 Results 4Health News:West Announces First Quarter 2009 Results 5Health News:West Announces First Quarter 2009 Results 6Health News:West Announces First Quarter 2009 Results 7Health News:West Announces First Quarter 2009 Results 8Health News:West Announces First Quarter 2009 Results 9Health News:West Announces First Quarter 2009 Results 10Health News:West Announces First Quarter 2009 Results 11Health News:West Announces First Quarter 2009 Results 12Health News:West Announces First Quarter 2009 Results 13Health News:West Announces First Quarter 2009 Results 14Health News:West Announces First Quarter 2009 Results 15Health News:West Announces First Quarter 2009 Results 16Health News:West Announces First Quarter 2009 Results 17Health News:West Announces First Quarter 2009 Results 18Health News:Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification 2Health News:Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification 3Health News:Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification 4Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 2Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 3Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 4Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 5Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 6Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 7Health News:Nutraceutical Reports Fiscal 2009 Q2 Results 8Health News:Gentiva Reports First Quarter 2009 Results 2Health News:Gentiva Reports First Quarter 2009 Results 3Health News:Gentiva Reports First Quarter 2009 Results 4Health News:Gentiva Reports First Quarter 2009 Results 5Health News:Gentiva Reports First Quarter 2009 Results 6Health News:Gentiva Reports First Quarter 2009 Results 7Health News:Gentiva Reports First Quarter 2009 Results 8Health News:Gentiva Reports First Quarter 2009 Results 9
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: